Companies: 10,795·Total market cap: $144.5T
Acro Biomedical Co., Ltd.

Acro Biomedical Co., Ltd.

ACBMOTCHealthcare● Active
$0.03
+$0.00(+0.00%)
Market Cap$1561092
P/E Ratio—
52W High$0.1
52W Low$0.0007
SEC Filings

Acro Biomedical Co., Ltd. (ACBM) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001622996 · ACBM · OTC · as of Jun 9, 2026

Filing snapshot

89
Total Filings
10-Q
Latest Form
2026-05-05
Most Recent
2021
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001622996 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-02-11
Fiscal Year End
Feb 11, 2026
Accession No.
0001640334-26-000241
Primary Document
acbm_10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001622996 · Accession 0001640334-26-000241

Latest Key Filings

10-QQuarterly Report
FORM 10-Q
2026-05-05
View 10-Q on SEC
8-KCurrent Report
FORM 8-K
2026-01-08Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
10-QQuarterly Report
FORM 10-Q
2026-05-05
View
10-KAnnual Report
FORM 10-K
2026-02-11
View
8-KCurrent Report
FORM 8-K
2026-01-08
View
10-QQuarterly Report
FORM 10-Q
2025-11-10
View
8-KCurrent Report
FORM 8-K
2025-08-14
View
10-QQuarterly Report
FORM 10-Q
2025-08-05
View
10-QQuarterly Report
FORM 10-Q
2025-07-24
View
10-KAnnual Report
FORM 10-K
2025-07-24
View
10-QQuarterly Report
FORM 10-Q
2025-07-23
View
10-QQuarterly Report
FORM 10-Q
2025-07-23
View
10-QQuarterly Report
FORM 10-Q
2025-07-22
View
10-KAnnual Report
FORM 10-K
2025-07-18
View
10-QQuarterly Report
FORM 10-Q
2025-07-11
View
8-KCurrent Report
FORM 8-K
2025-07-02
View
NT 10-QNT 10-Q
FORM 12B-25
2023-11-15
View
Showing 1–15 of 89 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001622996  |  Exchange: OTC · Healthcare

Acro Biomedical Co., Ltd. (OTC: ACBM) has submitted 89 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Healthcare sector company with CIK 0001622996, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Acro Biomedical Co., Ltd.'s most comprehensive regulatory disclosure. The most recent Acro Biomedical Co., Ltd. 10-K was filed on 2026-02-11 for fiscal year ending 2026. Historical ACBM 10-K annual reports are available from 2014 through 2026.

Investors researching Acro Biomedical Co., Ltd. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
NSPDF SEC Filings →MLPH SEC Filings →BSSP SEC Filings →HDVY SEC Filings →IGRW SEC Filings →AMBS SEC Filings →ITMC SEC Filings →ONBI SEC Filings →
→ ACBM Financials→ ACBM Earnings→ ACBM Insider Trades

Frequently Asked Questions

ACBM SEC Filings · 8 questions

Acro Biomedical Co., Ltd. (ACBM) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 89 filings and access original documents at no cost. Acro Biomedical Co., Ltd.'s CIK is 0001622996.

ACBM SEC filingsAcro Biomedical Co., Ltd. SEC documentsfind ACBM 10-K